AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia

MLA

Manesh, Dm, et al. AKR1C3 Is a Biomarker of Sensitivity to PR-104 in Preclinical Models of T-Cell Acute Lymphoblastic Leukemia. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1031070758&authtype=sso&custid=ns315887.

APA

Manesh, D., El-Hoss, J., Evans, K., Richmond, J., Toscan, C., Bracken, L., Hedrick, A., Sutton, R., Marshall, G., Wilson, W., Kurmasheva, R., Billups, C., Houghton, P., Smith, M., Carol, H., & Lock, R. (2015). AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia.

Chicago

Manesh, Dm, J El-Hoss, K Evans, J Richmond, Ce Toscan, Ls Bracken, A Hedrick, et al. 2015. “AKR1C3 Is a Biomarker of Sensitivity to PR-104 in Preclinical Models of T-Cell Acute Lymphoblastic Leukemia.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1031070758&authtype=sso&custid=ns315887.